Infonalé - Media - Releases

The Blood Management Company

OUR MISSION:
To provide the hospital industry with clinical benefits to the patient and economic advantages
to the hospital through implementation of best practices blood management programs.

Media - Releases - 20071004

Haemonetics/Infonalé's Presence at 2007 SABM Annual Meeting

The Society for the Advancement of Blood Management (SABM) 2007 Sixth Annual Meeting was held at the Renaissance Hollywood Hotel in Hollywood, California on September 7–9, 2007. Haemonetics made a huge visual commitment to its mission: Blood Management . . . Bringing it All together. A 20-foot x 20-foot booth, complete with continuing blood management education, launched a new corporate visual identity that introduced Infonalé as a new Haemonetics company to the industry.

Haemonetics/Infonalé presence was established with the display of six clinical poster abstracts, participation in an Autotransfusion Forum, and a satellite-dinner symposium on perioperative anemia management “directed” by Dr. Richard Spence.

Autotransfusion Forum
There were four panelists on the Autotransfusion Forum. Dr. Jonathan Waters indicated that “cell salvage is a most effective blood management technique”. Dr. Mark Popovsky followed with a discussion of the economics of allogeneic blood use. He said: “The cost of blood is much higher than we think.” Next, Dr. Paula Santrach discussed her findings regarding the low incidence of bacterial infection during cell salvage. Finally, Dr. Ty Walker addressed his personal successes with the perioperative use of cardioPAT.

Satellite-Dinner Symposium
Dr. Spence played the director of a “Hollywood-style” educational symposium on Saturday evening. The audience was tested with electronic, real-time polling to assess the way they would treat hypothetical scenarios involving anemia.

Then ‘Director’ Spence guided the cast of experts, Dr. Tim Goodnough, Dr. Aryeh Shander, and Patricia Parce, in data-driven discussions regarding the science and application of preoperative anemia management. “Cast members lay out the facts and concepts in a charming and engaging style and, by the end, hold everyone spellbound by their compelling message”, said Dr. Spence.

Learning objectives included developing protocols for routine screening for and diagnosis of anemia four weeks before elective surgery; identifying patients for whom erythropoiesis stimulating agents (ESAs) may be indicated; safely decreasing the rate of allogeneic transfusions to surgical patients; and analyzing the cost/benefit for treating anemia preoperatively with ESAs vs. perioperatively with allogeneic transfusion.

The symposium provided ample evidence to support the development of a collaborative preoperative anemia management program in all surgical facilities.

###

Contact: Julie Fallon
Tel: (781) 356-9517
Alt. Tel: (617) 320-2401
fallon@haemonetics.com